logo
Plus   Neg
Share
Email

Johnson Controls Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the second quarter on Friday, Johnson Controls International plc (JCI) said it is withdrawing its previously communicated fiscal year 2020 guidance, as a result of the challenging and uncertain macro environment attributable to the impact the novel coronavirus (COVID-19) pandemic.

However, the company provided a framework related to the second half of the fiscal year. It expects organic revenue decline of 15 to 20 percent.

The company suspended its share repurchase program in mid-March, but maintained its quarterly dividend.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT